Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AEMDNYSE:ALURNASDAQ:NEPHNYSE:RVP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAEMDAethlon Medical$0.40-0.3%$0.38$0.24▼$1.06$6.39M1.932.36 million shs159,977 shsALURAllurion Technologies$2.78-5.9%$2.67$2.15▼$88.75$20.81M-0.58772,256 shs149,920 shsNEPHNephros$2.92+11.0%$1.94$1.36▼$2.96$30.95M0.8112,317 shs75,079 shsRVPRetractable Technologies$0.65+1.4%$0.72$0.56▼$1.22$19.43M1.6575,858 shs56,123 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAEMDAethlon Medical0.00%-1.19%+6.02%-31.80%-6.81%ALURAllurion Technologies0.00%-12.43%+21.75%-21.80%-93.19%NEPHNephros0.00%+35.19%+50.52%+86.11%+31.53%RVPRetractable Technologies0.00%-9.86%-13.35%-22.74%-29.26%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAEMDAethlon Medical1.6608 of 5 stars3.53.00.00.00.00.01.3ALURAllurion Technologies3.4082 of 5 stars3.55.00.00.02.43.30.6NEPHNephros1.8998 of 5 stars3.55.00.00.00.60.80.0RVPRetractable TechnologiesN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAEMDAethlon Medical 3.00Buy$7.001,659.24% UpsideALURAllurion Technologies 3.00Buy$22.83722.53% UpsideNEPHNephros 3.00Buy$5.0071.23% UpsideRVPRetractable Technologies 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest AEMD, ALUR, NEPH, and RVP Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/27/2025ALURAllurion TechnologiesChardan CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$2.50 ➝ $2.503/21/2025ALURAllurion TechnologiesRoth MkmSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$16.00 ➝ $16.003/21/2025ALURAllurion TechnologiesChardan CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$2.503/10/2025AEMDAethlon MedicalHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$7.00 ➝ $7.00(Data available from 5/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAEMDAethlon Medical$570K11.21N/AN/A$2.19 per share0.18ALURAllurion Technologies$28.30M0.73N/AN/A($36.95) per share-0.08NEPHNephros$15.52M1.99N/AN/A$0.80 per share3.65RVPRetractable Technologies$33.75M0.58$0.01 per share48.25$3.31 per share0.20Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAEMDAethlon Medical-$12.21M-$1.58N/AN/AN/AN/A-153.96%-109.13%6/26/2025 (Estimated)ALURAllurion Technologies-$80.61M-$12.50N/AN/AN/A-71.24%N/A-56.75%8/12/2025 (Estimated)NEPHNephros-$1.58M$0.07N/A∞N/A-6.86%-11.39%-8.30%8/6/2025 (Estimated)RVPRetractable Technologies-$7.01M-$0.77N/A∞N/A-41.11%-17.15%-9.33%N/ALatest AEMD, ALUR, NEPH, and RVP EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025NEPHNephros-$0.0050$0.0526+$0.0576$0.05$3.67 million$4.88 million5/14/2025Q1 2025ALURAllurion Technologies-$1.53$0.43+$1.96$0.20$5.50 million$5.58 million3/26/2025Q4 2024ALURAllurion Technologies-$5.00-$7.00-$2.00-$7.95$5.60 million$5.59 million3/24/2025Q4 2024NEPHNephros-$0.01$0.03+$0.04$0.03$3.67 million$3.87 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAEMDAethlon MedicalN/AN/AN/AN/AN/AALURAllurion TechnologiesN/AN/AN/AN/AN/ANEPHNephrosN/AN/AN/AN/AN/ARVPRetractable TechnologiesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAEMDAethlon MedicalN/A2.802.80ALURAllurion TechnologiesN/A2.332.09NEPHNephrosN/A6.954.02RVPRetractable Technologies0.018.575.92Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAEMDAethlon Medical1.99%ALURAllurion Technologies21.39%NEPHNephros41.10%RVPRetractable Technologies7.58%Insider OwnershipCompanyInsider OwnershipAEMDAethlon Medical1.10%ALURAllurion Technologies22.40%NEPHNephros6.70%RVPRetractable Technologies57.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAEMDAethlon Medical1016.06 million14.30 millionNo DataALURAllurion Technologies5017.46 million2.01 millionOptionableNEPHNephros3010.60 million10.11 millionNot OptionableRVPRetractable Technologies24029.94 million13.47 millionOptionableAEMD, ALUR, NEPH, and RVP HeadlinesRecent News About These CompaniesWall Street Zen Initiates Coverage on Retractable Technologies (NYSE:RVP)May 23 at 3:33 AM | americanbankingnews.comThomas J. Shaw Buys 86,014 Shares of Retractable Technologies, Inc. (NYSE:RVP) StockMay 17, 2025 | insidertrades.comRetractable Technologies (NYSE:RVP) Coverage Initiated at StockNews.comMay 16, 2025 | americanbankingnews.comRetractable Technologies, Inc. Results for the Period Ended March 31, 2025 | RVP Stock NewsMay 15, 2025 | gurufocus.comRetractable Technologies, Inc. Results for the Period Ended March 31, 2025May 15, 2025 | businesswire.comRetractable Technologies, Inc. (NYSE:RVP) CEO Buys $10,037.25 in StockMay 15, 2025 | insidertrades.comThomas J. Shaw Purchases 22,620 Shares of Retractable Technologies, Inc. (NYSE:RVP) StockMay 7, 2025 | insidertrades.comInsider Buying: Retractable Technologies, Inc. (NYSE:RVP) CEO Buys 16,165 Shares of StockApril 24, 2025 | insidertrades.comInsider Buying: Retractable Technologies, Inc. (NYSE:RVP) CEO Purchases 33,524 Shares of StockApril 15, 2025 | insidertrades.comLittle Elm's Retractable Technologies announces 7% workforce reduction due to tariffsApril 11, 2025 | starlocalmedia.comRetractable Technologies cuts workforce to reduce reliance on China amid trade warApril 11, 2025 | drugdeliverybusiness.comRetractable Technologies announces 7% workforce reductionApril 11, 2025 | markets.businessinsider.comRetractable Technologies, Inc. Announces Reduction in WorkforceApril 10, 2025 | businesswire.comRetractable Technologies, Inc. Reports Results for 2024March 28, 2025 | businesswire.comRetractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock ShareholdersMarch 28, 2025 | investing.comRetractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock ShareholdersMarch 28, 2025 | businesswire.comThomas J. Shaw Buys 18,227 Shares of Retractable Technologies, Inc. (NYSE:RVP) StockFebruary 5, 2025 | insidertrades.comRetractable Technologies CEO Thomas Shaw acquires $14,082 in stockFebruary 4, 2025 | msn.comRetractable Technologies, Inc. (NYSE:RVP) CEO Acquires $10,080.45 in StockJanuary 29, 2025 | insidertrades.comRetractable technologies CEO Thomas Shaw acquires shares worth $10,105January 28, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeAEMD, ALUR, NEPH, and RVP Company DescriptionsAethlon Medical NASDAQ:AEMD$0.40 0.00 (-0.28%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$0.39 -0.01 (-1.99%) As of 05/23/2025 05:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.Allurion Technologies NYSE:ALUR$2.78 -0.17 (-5.90%) Closing price 05/23/2025 03:58 PM EasternExtended Trading$2.86 +0.08 (+3.03%) As of 05/23/2025 06:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.Nephros NASDAQ:NEPH$2.92 +0.29 (+11.03%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$2.82 -0.11 (-3.60%) As of 05/23/2025 07:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.Retractable Technologies NYSE:RVP$0.65 +0.01 (+1.39%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$0.66 +0.01 (+1.85%) As of 05/23/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/19 - 05/23 Trade Desk Silences Critics; Recovery Looks Poised to Continue Alphabet Stock Lags—But Waymo May Be Its Hidden Driver This Market Sell-Off Might Trigger a Value Rotation Into Pepsi Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH Stock Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
